Sharon Rodriguez is bringing her 25+ years of global experience to 1843 Capital as Partner – a move that will help the venture capital firm expand its portfolio in the growing AgeTech and Longevity market. Sharon has a proven track record of catalyzing top-line revenue growth, building strong teams and cultures, optimizing customer experience, and achieving outsized outcomes. Her experience in all aspects of customer success, engagement, healthcare and insurance positions her uniquely to lead 1843 Capital’s efforts in investing in financial longevity.
1843 Capital has fully deployed Fund 1 and is investing from Fund 2. With the new fund, and the addition of Sharon, 1843 intends to increase its reach and value add to investee companies. 1843 offers “Capital, Connectivity and Counsel” to its portfolio.
“Sharon brings to 1843 Capital immense experience across the investment lifecycle from deal sourcing and adding new perspective in our due diligence, to portfolio company advisory,” says Tracy Chadwell, 1843 Capital Founding Partner. “She’s an invaluable addition as we begin investing in 1843 Capital Fund II and focusing heavily in the growing AgeTech and Longevity market.”
“In the VC space, only 12% of decision makers are women; I’m truly excited to join 1843 Capital which was founded and run by women,” says Sharon. “The team had tremendous success with Fund 1. I look forward to working together to continue investing in technologies geared toward improving the lives of our rapidly aging population as we focus on Fund 2 and beyond.”
Prior to joining 1843 Capital, Sharon was a founding team member of Unqork and served as Chief Customer Officer, for the enterprise, no-code, SaaS platform. At Unqork, Sharon helped to create a market-responsive business model and built all customer-facing functions as well as was a long-time supporter of the firm’s DEI initiatives.
Prior to Unqork, Sharon was the Head of Global Application Development Strategy at MetLife where she transformed a siloed, local-level management model into a cohesive global organization by defining roles for planning and execution on global decisions.
Sharon also served as Senior VP Operations at AIG and began her career in pharmaceuticals at Pfizer. She holds a BS in Biology from Eckerd College and an MBA from the Wharton School with a dual emphasis in Finance and Healthcare Management.